Schedule 13G ownership disclosure
IN8bio, Inc.
Common Stock, $0.0001 par value per share · CUSIP: 45674E208
Event date: 2025-12-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 683 Capital Management, LLC
Shares: 770,445 · Class: 7.86%
- 683 Capital Partners, LP
Shares: 770,445 · Class: 7.86%
- Ari Zweiman
Shares: 770,445 · Class: 7.86%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001404574-25-000008
- Form type
- SCHEDULE 13G
- Filer
- 683 Capital Management, LLC
- CIK
- CIK 1404574
- Filed
- Dec 30, 2025
- Reporting period
- Dec 22, 2025
- Description
- Schedule 13G beneficial ownership